NCT02307825 - Azithromycin for Patients With Chronic Rhinosinusitis Failing Medical and Surgical Therapy | Biotech Hunter

Enrollment

129

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

August 15, 2017

Study Completion Date

December 31, 2017

Conditions

Chronic RhinosinusitisHigh-risk Patient

Interventions

DRUG

Azithromycin

The drug will be taken three times a week for four months.

DRUG

Placebo

The placebo will be taken three times a week for four months.

Trial Locations (1)

Centre Hospitalier de l'Université de Montréal (CHUM), Montreal